Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics
Top Cited Papers
Open Access
- 3 May 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 913
- https://doi.org/10.3389/fmicb.2019.00913
Abstract
The ESKAPE pathogen Pseudomonas aeruginosa is recognized as an important cause of chronic infections due to its ability to form biofilms where the bacteria are present in aggregates encased in a self-produced extracellular matrix and are difficult or impossible to eradicate with antibiotic treatment. P. aeruginosa is causing chronic infections in the lungs of patients with cystic fibrosis and chronic obstructive lung disease, as well as chronic urinary tract infections in patients with permanent bladder catheter, and ventilator-associated pneumonia in intubated patients, and is also an important pathogen in chronic wounds. Antibiotic treatment cannot eradicate these biofilm infections due to their intrinsic antibiotic tolerance and the development of mutational antibiotic resistance. The tolerance of biofilms to antibiotics is multifactorial involving physical, physiological and genetic determinants, whereas the antibiotic resistance of bacteria in biofilms is caused by mutations and driven by the repeated exposure of the bacteria to high levels of antibiotics. In this review both the antimicrobial tolerance and the development of resistance to antibiotics in P. aeruginosa biofilms is discussed. Possible therapeutic approaches based on the understanding of the mechanisms involved in the tolerance and resistances of biofilms to antibiotics are also addressed.Keywords
Funding Information
- Danish Council for Independent Research
This publication has 158 references indexed in Scilit:
- Extracellular DNA Shields against Aminoglycosides in Pseudomonas aeruginosa BiofilmsAntimicrobial Agents and Chemotherapy, 2013
- Expression of Fap amyloids in Pseudomonas aeruginosa,P. fluorescens, and P. putida results in aggregation and increased biofilm formationMicrobiologyopen, 2013
- Dynamics of Mutator and Antibiotic-Resistant Populations in a Pharmacokinetic/Pharmacodynamic Model of Pseudomonas aeruginosa Biofilm TreatmentAntimicrobial Agents and Chemotherapy, 2011
- Pseudomonas aeruginosa uses a cyclic‐di‐GMP‐regulated adhesin to reinforce the biofilm extracellular matrixMolecular Microbiology, 2010
- Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytesAPMIS, 2009
- Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogenGenes & Development, 2009
- Endogenous oxidative stress produces diversity and adaptability in biofilm communitiesProceedings of the National Academy of Sciences of the United States of America, 2008
- Source–sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness costProceedings. Biological sciences, 2007
- Stress-Induced Mutagenesis in BacteriaCritical Reviews in Biochemistry and Molecular Biology, 2007
- Aminoglycoside antibiotics induce bacterial biofilm formationNature, 2005